208 related articles for article (PubMed ID: 28412208)
1. High expression of P2X7R is an independent postoperative indicator of poor prognosis in colorectal cancer.
Qian F; Xiao J; Hu B; Sun N; Yin W; Zhu J
Hum Pathol; 2017 Jun; 64():61-68. PubMed ID: 28412208
[TBL] [Abstract][Full Text] [Related]
2. PI3K/Akt/GSK-3β signal pathway is involved in P2X7 receptor-induced proliferation and EMT of colorectal cancer cells.
Zhang WJ; Luo C; Huang C; Pu FQ; Zhu JF; Zhu ZM
Eur J Pharmacol; 2021 May; 899():174041. PubMed ID: 33737010
[TBL] [Abstract][Full Text] [Related]
3. The role of P2X7 receptor in prognosis and metastasis of colorectal cancer.
Zhang Y; Ding J; Wang L
Adv Med Sci; 2019 Sep; 64(2):388-394. PubMed ID: 31276917
[TBL] [Abstract][Full Text] [Related]
4. P2X7 receptor as an independent prognostic indicator in gastric cancer.
Calik I; Calik M; Sarikaya B; Ozercan IH; Arslan R; Artas G; Dagli AF
Bosn J Basic Med Sci; 2020 May; 20(2):188-196. PubMed ID: 32070268
[TBL] [Abstract][Full Text] [Related]
5. Gab2 is a novel prognostic factor for colorectal cancer patients.
Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
[TBL] [Abstract][Full Text] [Related]
6. SEMA3F prevents metastasis of colorectal cancer by PI3K-AKT-dependent down-regulation of the ASCL2-CXCR4 axis.
Zhou ZH; Rao J; Yang J; Wu F; Tan J; Xu SL; Ding Y; Zhan N; Hu XG; Cui YH; Zhang X; Dong W; Liu XD; Bian XW
J Pathol; 2015 Aug; 236(4):467-78. PubMed ID: 25866254
[TBL] [Abstract][Full Text] [Related]
7. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
8. High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer.
Wang C; Zhou Y; Ruan R; Zheng M; Han W; Liao L
Int J Clin Exp Pathol; 2015; 8(6):7112-21. PubMed ID: 26261604
[TBL] [Abstract][Full Text] [Related]
9. Progress in the relationship between P2X7R and colorectal cancer.
Bai X; Li X; Qiao C; Tang Y; Zhao R; Peng X
Mol Biol Rep; 2023 Feb; 50(2):1687-1699. PubMed ID: 36417079
[TBL] [Abstract][Full Text] [Related]
10. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
Gao JY; Song BR; Peng JJ; Lu YM
World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
12. A438079 affects colorectal cancer cell proliferation, migration, apoptosis, and pyroptosis by inhibiting the P2X7 receptor.
Zhang Y; Li F; Wang L; Lou Y
Biochem Biophys Res Commun; 2021 Jun; 558():147-153. PubMed ID: 33915328
[TBL] [Abstract][Full Text] [Related]
13. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
14. A promising independent prognostic biomarker in colorectal cancer: P2X7 receptor.
Calik I; Calik M; Turken G; Ozercan IH
Int J Clin Exp Pathol; 2020; 13(2):107-121. PubMed ID: 32211091
[TBL] [Abstract][Full Text] [Related]
15. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.
Xu X; Chang W; Yuan J; Han X; Tan X; Ding Y; Luo Y; Cai H; Liu Y; Gao X; Liu Q; Yu Y; Du Y; Wang H; Ma L; Wang J; Chen K; Ding Y; Fu C; Cao G
Oncotarget; 2016 Jan; 7(1):798-813. PubMed ID: 26556874
[TBL] [Abstract][Full Text] [Related]
16. The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways.
Tian XY; Li J; Liu TH; Li DN; Wang JJ; Zhang H; Deng ZL; Chen FJ; Cai JP
Cancer Med; 2020 Nov; 9(22):8612-8623. PubMed ID: 33016643
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of forkhead box protein A1 and its role in colorectal cancer.
Ma W; Jiang J; Li M; Wang H; Zhang H; He X; Huang L; Zhou Q
Mol Med Rep; 2016 Sep; 14(3):2625-31. PubMed ID: 27484093
[TBL] [Abstract][Full Text] [Related]
18. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
[TBL] [Abstract][Full Text] [Related]
19. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B.
Tafani M; Schito L; Pellegrini L; Villanova L; Marfe G; Anwar T; Rosa R; Indelicato M; Fini M; Pucci B; Russo MA
Carcinogenesis; 2011 Aug; 32(8):1167-75. PubMed ID: 21642357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
